Recent Finacing
Recent Raise
AMLo Biosciences, a Newcastle University spin‑out, develops AMBLor, a prognostic 'rule‑out' test that identifies low‑risk early‑stage melanomas to enable risk stratification and reduce invasive surveillance.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Amlo Biosciences.
